Impaired atrial natriuretic peptide-mediated lipolysis in obesity

International Journal of Obesity

Volumn 40, Issue 4, 2016, Pages 714-720

  Ryden M ^a   Backdahl J ^a   Petrus, P ^a   Thorell, A ^b   Gao, H ^c   Coue, M ^d   Langin, D ^d,e   Moro, C ^d   Arner, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d University Hospital of Toulouse   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; GLIBENCLAMIDE PLUS METFORMIN; LIPID; METFORMIN; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C;

ADIPOCYTE; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CELL COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; MAJOR CLINICAL STUDY; MICRODIALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH BYPASS; WEIGHT REDUCTION; ABDOMINAL SUBCUTANEOUS FAT; COMPLICATION; ENERGY METABOLISM; GENE EXPRESSION REGULATION; MALE; METABOLISM; PATHOPHYSIOLOGY; WESTERN BLOTTING;

ADIPOCYTES; ADULT; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CATECHOLAMINES; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPOLYSIS; MALE; MICRODIALYSIS; OBESITY; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84949024081     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.222     Document Type: Article

References (35)

1. Pandey KN. Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation. Can J Physiol Pharmacol 2011; 89: 557-573.
2. Gruden G, Landi A, Bruno G. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research. Diabetes Care 2014; 37: 2899-2908.
3. Magnusson M, Jujic A, Hedblad B, Engstrom G, Persson M, Struck J et al. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J Clin Endocrinol Metab 2012; 97: 638-645.
4. Lazo M, Young JH, Brancati FL, Coresh J, Whelton S, Ndumele CE et al. NH2-Terminal pro-brain natriuretic peptide and risk of diabetes. Diabetes 2013; 62: 3189-3193.
5. Meirhaeghe A, Sandhu MS, McCarthy MI, de Groote P, Cottel D, Arveiler D et al. Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 2007; 16: 1343-1350.
6. Moro C, Lafontan M. Natriuretic peptides and cGMP signaling control of energy homeostasis. Am J Physiol Heart Circ Physiol 2013; 304: H358-H368.
7. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000; 14: 1345-1351.
8. Misono KS, Philo JS, Arakawa T, Ogata CM, Qiu Y, Ogawa H et al. Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase. FEBS J 2011; 278: 1818-1829.
9. Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A. Regulation of adipocyte lipolysis. Nutr Res Rev 2014; 27: 63-93.
10. Moro C, Klimcakova E, Lafontan M, Berlan M, Galitzky J. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis. Br J Pharmacol 2007; 152: 1102-1110.
11. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005; 19: 471-482.
12. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M et al. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 2001; 42: 536-544.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-Density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Kolaczynski JW, Morales LM, Moore Jr JH , Considine RV, Pietrzkowski Z, Noto PF et al. A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. Int J Obes Relat Metab Disord 1994; 18: 161-166.
16. Ryden M, Andersson DP, Bergstrom IB, Arner P. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. J Clin Endocrinol Metab 2014; 99: E1870-E1876.
17. Arner P, Backdahl J, Hemmingsson P, Stenvinkel P, Eriksson-Hogling D, Naslund E et al. Regional variations in the relationship between arterial stiffness and adipocyte volume or number in obese subjects. Int J Obes (Lond) 2015; 39: 222-227.
18. Arner P, Andersson DP, Thorne A, Wiren M, Hoffstedt J, Naslund E et al. Variations in the size of the major omentum are primarily determined by fat cell number. J Clin Endocrinol Metab 2013; 98: E897-E901.
19. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-Adrenoceptors. Diabetologia 1994; 37: 428-435.
20. Kenakin T. Principles: receptor theory in pharmacology. Trends Pharmacol Sci 2004; 25: 186-192.
21. Langin D, Dicker A, Tavernier G, Hoffstedt J, Mairal A, Ryden M et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005; 54: 3190-3197.
22. Laurencikiene J, Skurk T, Kulyte A, Heden P, Astrom G, Sjolin E et al. Regulation of lipolysis in small and large fat cells of the same subject. J Clin Endocrinol Metab 2011; 96: E2045-E2049.
23. Enoksson S, Nordenström J, Bolinder J, Arner P. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Relat Metab Disord 1995; 19: 350-354.
24. Bradley DC, Kaslow HR. Radiometric assays for glycerol, glucose, and glycogen. Anal Biochem 1989; 180: 11-16.
25. Bernst E, Gutman I. Determination of ethanol with alcohol dehydrogenase and NAD. In: Bergmeyer HU (ed), Methods of Enzymatic Analysis. Weinheim: Verlag, 1974, pp 1499-1505.
26. Gao H, Mejhert N, Fretz JA, Arner E, Lorente-Cebrian S, Ehrlund A et al. Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab 2014; 19: 981-992.
27. Arner P, Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesityinduced insulin resistance. Trends Endocrinol Metab 2014; 25: 255-262.
28. Andersson DP, Eriksson Hogling D, Thorell A, Toft E, Qvisth V, Naslund E et al. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss. Diabetes Care 2014; 37: 1831-1836.
29. Arner E, Mejhert N, Kulyte A, Balwierz PJ, Pachkov M, Cormont M et al. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 2012; 61: 1986-1993.
30. Yu J, Yu HC, Kim KA, Kwon KB, Park JW, Kim SZ et al. Differences in the amount of lipolysis induced by atrial natriuretic peptide in small and large adipocytes. J Pept Sci 2008; 14: 972-977.
31. Omar B, Banke E, Ekelund M, Frederiksen S, Degerman E. Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity. Nutr Diabetes 2011; 1: e13.
32. Degerman E, Ahmad F, Chung YW, Guirguis E, Omar B, Stenson L et al. From PDE3B to the regulation of energy homeostasis. Curr Opin Pharmacol 2011; 11: 676-682.
33. Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 2015; 16: 22.
34. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001; 4: 499-502.
35. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003; 24: 276-283.